A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review

September 2021 | 35 pages | ID: AC6617A6097EN
GlobalData

Abstracts

A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

A. Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company that undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio is focused on a several therapeutic and wellness areas, including allergy, andrology, ant infective areas, cardiovascular areas, gastrointestinal disorders, gynecology and women's wellness, respiratory areas, rheumatology, osteoporosis, dermatology and personal care, energy supplements and multivitamins, among others. Menarini operates through its manufacturing sites, research and development centers and has presence across Europe and Asia, Africa, Central and South America. It distributes products across various countries worldwide through partners and distributors. Menarini is headquartered in Florence, Italy.

A. Menarini Industrie Farmaceutiche Riunite Srl Key Recent Developments

Jul 22,2021: Menarini Asia-Pacific strengthens Men’s Health portfolio in China with acquisition of Cialis (Tadalafil) from Lilly
May 14,2021: Menarini receives the coveted M&A Award 2021 for the 2020 acquisition of US company Stemline Therapeutics
Jan 22,2021: Menarini: Blastic Plasmacytoid Dendritic Cell Neoplasm Awareness Day
Dec 16,2020: Menarini Group awarded the coveted XV Transatlantic award from American Chamber of Commerce in Italy
Nov 06,2020: Menarini against cancer: for a child, ‘home’ means family

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

A. Menarini Industrie Farmaceutiche Riunite Srl - Key Facts
A. Menarini Industrie Farmaceutiche Riunite Srl - Key Employees
A. Menarini Industrie Farmaceutiche Riunite Srl - Major Products and Services
A. Menarini Industrie Farmaceutiche Riunite Srl - History
A. Menarini Industrie Farmaceutiche Riunite Srl - Company Statement
A. Menarini Industrie Farmaceutiche Riunite Srl - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
A. Menarini Industrie Farmaceutiche Riunite Srl - Business Description
A. Menarini Industrie Farmaceutiche Riunite Srl - SWOT Analysis
SWOT Analysis - Overview
A. Menarini Industrie Farmaceutiche Riunite Srl - Strengths
A. Menarini Industrie Farmaceutiche Riunite Srl - Weaknesses
A. Menarini Industrie Farmaceutiche Riunite Srl - Opportunities
A. Menarini Industrie Farmaceutiche Riunite Srl - Threats
A. Menarini Industrie Farmaceutiche Riunite Srl - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
A. Menarini Industrie Farmaceutiche Riunite Srl, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 14, 2021: Menarini receives the coveted M&A Award 2021 for the 2020 acquisition of US company Stemline Therapeutics
Jan 22, 2021: Menarini: Blastic Plasmacytoid Dendritic Cell Neoplasm Awareness Day
Dec 16, 2020: Menarini Group awarded the coveted XV Transatlantic award from American Chamber of Commerce in Italy
Nov 06, 2020: Menarini against cancer: for a child, ‘home’ means family
Jun 10, 2020: Menarini Group completes a solid year of operating performance
Jun 05, 2020: Menarini invests 150 million Euros in a new pharmaceutical plant in Italy
May 05, 2020: Menarini Group to buy Stemline Therapeutics in deal valued at $677m
Apr 25, 2020: Covid-19: Menarini continues with further donations and reaches a record production of 100 tonnes of disinfectant gel

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

A. Menarini Industrie Farmaceutiche Riunite Srl, Key Facts
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Employees
A. Menarini Industrie Farmaceutiche Riunite Srl, Major Products and Services
A. Menarini Industrie Farmaceutiche Riunite Srl, History
A. Menarini Industrie Farmaceutiche Riunite Srl, Subsidiaries
A. Menarini Industrie Farmaceutiche Riunite Srl, Joint Venture
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Competitors
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
A. Menarini Industrie Farmaceutiche Riunite Srl, Recent Deals Summary

List Of Figures

LIST OF FIGURES

A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021